| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000029053 |
| Receipt No. | R000033231 |
| Official scientific title of the study | Study on body fat reducing effect of dietary supplement -A randomized, double blind, placebo-controlled, parallel group study- |
| Date of disclosure of the study information | 2017/09/08 |
| Last modified on | 2017/09/08 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Study on body fat reducing effect of dietary supplement -A randomized, double blind, placebo-controlled, parallel group study- | |
| Title of the study (Brief title) | Study on body fat reducing effect of dietary supplement | |
| Region |
|
|
| Condition | |||
| Condition | Healthy subject | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | This study aims to evaluate the effect of the dietary supplement on body fat of subject aged 40 to 64 years with slightly high body mass index (BMI: 23 kg/m2 to less than 30 kg/m2). |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Abdominal fat area |
| Key secondary outcomes | Body weight, BMI, body fat percentage |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | No need to know |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intake of dietary supplement for 12 consecutive weeks | |
| Interventions/Control_2 | Intake of placebo for 12 consecutive weeks | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1)Vietnamese women between 40 and 65 years old at the time of obtaining informed consent.
2)BMI between 23 and 30kg/m2. 3)Waist circumference of at least 80cm. |
|||
| Key exclusion criteria | 1)The candidate is currently undergoing drug or exercise therapy.
2)The candidate currently has, or has a history of, diabetes, liver disease, kidney disease, heart disease, any disease that affects corticosteroid secretion, and/or any other metabolic disease. 3)There are concerns about the potential for the study foods to induce allergic symptoms in the candidate. 4)The candidate is pregnant, or intends to become pregnant or to breastfeed during the study period. 5)The candidate generally or routinely takes any medication that affects body fat and/or lipid metabolism, including over-the-counter drugs, quasi-drugs, and health foods. 6)The candidate is currently dieting with the aim of reducing body weight. 7)The candidate has participated in any other clinical study within the past 1month. |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Bui Thi Nhung |
| Organization | National Institute of Nutrition |
| Division name | - |
| Address | 48B-Tang Bat Ho, Hanoi-Vietnam |
| TEL | +84-43971-7090 |
| nhungvnnin@gmail.com | |
| Public contact | |
| Name of contact person | Yoshiki Shimizu |
| Organization | FANCL Corporataion |
| Division name | Research Institute |
| Address | 12-13 Kamishinano, Totsuka-ku, Yokohama, Kanagawa 244-0806, Japan |
| TEL | 045-820-3755 |
| Homepage URL | |
| shimizu_yoshiki@fancl.co.jp | |
| Sponsor | |
| Institute | FANCL Corporation |
| Institute | |
| Department | |
| Funding Source | |
| Organization | FANCL Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033231 |